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Location of an inducible nitric oxide synthase mRNA in the normal
kidney. An inducible nitric oxide synthase (iNOS) mRNA was found
primarily in the outer medulla of normal rat kidney. Identification of the
mRNA was based upon the specificity of the oligonucleotide primers
used for PCR amplification, PCR-Southern blot analysis and the nucleic
acid sequence of the cloned PCR product. In addition to the outer
medulla, glomeruli prepared from normal rat kidney contained signifi-
cant amounts of an iNOS mRNA. These results suggest that there may
be tonic influences in the outer medulla of the normal rat kidney
resulting in the "steady-state" presence of an iNOS mRNA. Cortical
tubules and the inner medulla were found to contain detectable but
lesser amounts of the iNOS mRNA. The outer medulla was microdis-
sected into proximal straight tubule (PST), medullary thick ascending
limb (MTAL), medullary collecting duct (MCD) and vasa recta bundle
(VRB). The iNOS mRNA was found primarily in the MTAL with minor
amounts in the MCD and VRB of normal rat kidney. Animals were
injected with lipopolysaccharide (LPS) and sacrificed 24 hours later.
Treatment with LPS caused at least a 20-fold increase in the amount of
iNOS mRNA in the liver or in macrophages isolated from the perito-
neum. Endotoxin treatment led to over a 10-fold increase in iNOS
mRNA content in glomeruli and the inner medulla. The iNOS mRNA
level of the outer medulla was increased two- to threefold due to LPS
treatment.
Nitric oxide (NO) serves as a signal molecule in the central
nervous system [1] and in the vasculature [2]. In addition, NO
has cytotoxic properties associated with macrophages [31. NO
is formed by a family of synthases distantly related to cyto-
chrome P450 reductase [4]. There are at least three distinct gene
products that produce nitric oxide synthase (NOS). The first
NOS gene sequenced was of an enzyme from the brain [4]. The
activity of brain NOS (bNOS) is calcium-calmodulin dependent
[4]. A second gene product from macrophages [5, 6] was also
described. The activity of this macrophage enzyme is not
dependent on added calmodulin [3, 6] although calmodulin is
part of the enzyme complex [7]. A third NOS gene product has
been detected in endothelial cells [8—10]. Like the brain en-
zyme, endothelial NOS (eNOS) is dependent on calcium-
calmodulin for activity [10] but, unlike bNOS, may be myristo-
lated [9]. Recently an inducible NOS activity has been
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described in hepatocytes (hNOS) which, while inducible, is
dependent on calcium-calmodulin for activity [11]. Both bNOS
and eNOS are constitutively expressed at low levels [1, 2].
Macrophages [3, 5, 6], hepatocytes [11], and endothelial cells
[12], however, contain inducible NOS enzymes [3, 6].
NO is an endothelial derived relaxing factor (EDRF) that is
acutely released in response to vasodilatory substances [2] or
released in a more sustained manner after cytokine-mediated
induction [3, 6]. NO is derived by the action of NOS on the
terminal guanidino nitrogen of the amino acid L-arginine [2, 3].
NO production can be blocked by L-arginine derivatives such
as N-monomethyl-L-arginine (NMA) or N-nitro-L-arginine me-
thylester (NAME) [2, 3]. Inhibitors of NO formation increase
blood pressure which affects renal blood flow and natriuresis
[13—15].
Glomeruli or mesangial cells in culture synthesize NO (mea-
sured as N021(N03) [16—18]. The nitrite production of ne-
phritic glomeruli may be due to macrophage infiltration [19].
Immunocytochemical studies have localized bNOS to the mac-
ula densa region of the kidney [20, 21]. The technique of reverse
transcription coupled to polymerase chain reaction (PCR) has
recently been applied to microdissected renal tubule segments
[221. Using this approach, Terada and co-workers have local-
ized bNOS mRNA primarily to the inner medullary collecting
duct [22]. Smaller amounts of bNOS mRNA were found along
the cortical and outer medullary collecting duct, inner medul-
lary thin limb, glomerulus and vasculature. Apart from a study
showing an endotoxin-mediated increase in glomerular nitrite!
nitrate production [23] and another demonstrating cytokine
stimulation of cultured renal proximal tubule and inner medul-
lary collecting duct cells [24], there have not been any studies
concerning the presence of iNOS in the kidney.
Methods
Animals
Female Sprague-Dawley rats (Harlan Sprague Dawley, Inc.,
Indianapolis, Indiana, USA) weighing 200 to 250 g were used in
all experiments. Some animals were injected with lipopolysac-
charide (LPS) (E. coli serotype 0l27:B8) at a dose of 0.1 mg/kg
24 hours prior to sacrifice [23]. All animals had free access to
water and rat chow (Ralston-Purina, St. Louis, Missouri,
USA).
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Fig. 1. AmpIfIcation of INOS cDNA (A) and GAPDH cDNA (B) by
PCR from different regions of the rat kidney. cDNA was prepared from
cortex (C), outer stripe (OS) and inner stripe (IS) of the outer medulla
(OM) and the inner medulla (IM). Amplification of the cDNA was for 35
cycles for iNOS and 30 cycles for GAPDH. An ethidium bromide
stained agarose gel of the PCR products is depicted along with sizing
standards,
Preparation of RNA
Animals were anesthetized with pentobarbital. The abdomen
of each animal was opened and the kidneys were perfused with
50 ml of ice-cold Hank's Balanced Salt Solution. The kidneys
were removed and decapsulated and a 2 mm sagittal section of
each kidney was made. The sections were placed in petri dishes
on ice filled with ice-cold balanced salt solution. Sections of
cortex, outer and inner stripe of the outer medulla and the inner
medulla were cut. These sections (50 to 100 mg tissue) were
immediately homogenized in 1 ml of RNAzo1 (Cinna Bioteck,
Houston, Texas, USA). In some experiments the remaining
cortex was dissected on ice, minced and processed by sieving to
yield glomeruli and cortical tubules [25]. The glomeruli and
cortical tubules were immediately homogenized in RNAzo1. In
additional experiments, resident peritoneal macrophages and
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Fig. 2. PCR-Southern analysis of iNOS cDNA in different regions of
the rat kidney. The agarose gel portrayed in Figure 1 was transferred to
a nylon membrane and hybridized with an antisense oligonucleotide
probe to iNOS mRNA as described in the Methods. An autoradiograph
replica is depicted along with sizing markers.
sections of the liver were also homogenized in RNAzol. Total
RNA from the different tissues or cells was precipitated from
each tissue extract with an equal volume of isopropanol in the
presence of 25 g of glycogen (Boehringer Mannheim Corp.,
Indianapolis, Indiana, USA). The total RNA was collected by
centnfugation and the resultant pellets were washed twice with
70% ethanol.
Microdissection and processing of the outer medulla
segments
Nephron segments (PST, MTAL, and MCD) and the VRB
were microdissected from the outer medulla of collagenase
preperfused rat kidney [25, 26]. The outer medulla was micro-
dissected in solution containing 10 mrvt vanadyl ribonucleoside
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Fig. 3. Amplification of 1NOS cDNA (A) and PCR-Southern analysis
(B)for iNOS in separated glomeruli (G) or tubules (T) prepared from rat
kidney cortex. cDNA was amplified for 35 cycles. The ethidium
bromide stained agarose gel (A) and the autoradiograph replica of the
Southern analysis (B) are depicted along with sizing standards.
(VRC) (Life Technologies, Inc., Gaithersburg, Maryland, USA)
as described [26] except that glass beads were not used for the
final rinses in VRC-free solution. The segments were individu-
ally transferred in 2 d of rinse solution into PCR tubes
containing 7 d of 2% Triton X-lOO, > 1 U/.d RNase inhibitor
and 5 mt dithiothreitol (DTT) [261. The total RNA of each
segment was isolated by the RNazol technique using 25 jxg of
glycogen to effect coprecipitation. Each pellet was washed
twice with 70% ethanol.
PCR amplification
Four micrograms of total RNA was reverse transcribed using
a kit from Invitrogen (San Diego, California, USA) with oligo
dT priming. For each amplification, the cDNA from 0.67 pg of
total RNA was used. The cDNA was amplified using prim-
ers 5'-GTGTFCCACCAGGAGATGTTG-3' (sense representing
amino acids 469-475) and 5'-CTCCTGCCCACTGAGTTCGTC-3'
(antisense representing amino acids 653—659) of murine iNOS [5,
6]. The cDNA of glyceraldehyde phosphate dehydrogenase
(GAPDH) was amplified using primers 5'-AATGCATCCTGCAC-
CACCAA-3' (sense) and 5'-GTAGCCATATTCATFGTCATA-3'
(antisense) [27]. The iNOS primers yielded a product of 576 bases
while the GAPDH primers yielded a product of 515 bases. PCR
amplifications were performed using an AmpliTaq kit (Perkin-
Elmer Corp., Norwalk, Connecticut, USA) and 50 pmole each
of the appropriate oligonucleotide primers. The amplification
conditions consisted of denaturation at 94°C for one minute,
annealing at 60°C for one minute and extension at 72°C for two
minutes. The number of cycles varied from 30 for GAPDH to 35
for iNOS.
A preliminary PCR amplification of GAPDH mRNA was
performed with one-tenth of each cDNA preparation of the
microdissected segments. This was used to gauge the amount of
cDNA needed for the iNOS mRNA amplifications which was
normalized to the amount of GAPDH mRNA.
Analysis of products
PCR amplification products were separated by means of 1.4%
agarose gels containing tris borate and EDTA buffer, with
added ethidium bromide. The gels were photographed using UV
light and Polaroid type 665 positive-negative film.
The products within the agarose gels were also denatured,
neutralized and transferred to positively charged nylon mem-
branes (Hybond-N , Amersham Corp., Arlington Heights,
Illinois, USA) as described by Sambrook, Fritsch and Maniatis
[281. The transferred nucleic acids were cross-linked to the
membrane by UV light (Stratagene, Lajolla, California, USA).
The membrane was prehybridized, hybridized and washed
using protocols developed by Amersham for the Enhanced
Chemiluminiscence (ECL) kits for oligonucleotides. An an-
tisense oligonucleotide probe representing amino acids 482—488
5'-(CTGGTCCATGCAGACAACCTT)-3' [5, 6] was end-la-
beled with 32P using T4 kinase (Promega, Madison, Wisconsin,
USA) as the hybridization probe.
Sequence of iNOS PCR products
The PCR amplified products from glomeruli and the inner
stripe of the outer medulla were ligated into the pCRII vector
(Invitrogen, San Diego, California, USA). Appropriate kana-
mycin-resistant clones were selected and the plasmid was
purified by columns and protocols developed by QIAGEN
(Chatsworth, California, USA). The plasmids were sequenced
using both forward and reverse primers with an AmpiTaq
sequencing kit (Perkin-Elmer Corp.) and deaza-dGTP termina-
tion mixes. The [35S]-labeled dideoxy terminated sequencing
mixes were separated by means of a 6% acrylamide TBE gel
containing 7 M urea and visualized by radioautography.
Results
PCR of INOS in the kidney
Amplification of total rat kidney cDNA by PCR uncovered a
product of the predicted 576 bp in size. Amplification products
of cDNA prepared from kidney cortex, outer stripe of the outer
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Fig. 4. Nucleic and amino acid sequence of the iNOS product of normal rat kidney. The sequence between the oligonucleotide primers is
depicted. Differences between the rat kidney INOS (shown) and the published murine macrophage 1NOS [5, 6] are indicated in lower case for the
nucleotides. The derived amino acid sequence is depicted above the nucleic acid sequence. Where a nucleotide change leads to an amino acid
change the mouse macrophage iNOS amino acid is illustrated below the nucleic acid sequence. The calmodulin and FMN binding regions based
upon the murine macrophage sequence [5] are shown. The numbers at the right margin refer to the position within the amino acid sequence of the
murine macrophage iNOS protein [5, 6].
medulla, inner stripe of the outer medulla and the inner medulla
are illustrated in Figure 1. The amount of cDNA used for iNOS
amplification (Fig. 1A) was normalized for the amount of
GAPDH amplification product seen at 515 bp (Fig. 1B). The
amount of iNOS cDNA was greatest in the outer stripe of the
outer medulla, followed by the amount in the inner stripe of the
outer medulla. By ethidium bromide staining there was barely
detectable iNOS cDNA present in the kidney cortex or the
inner medulla (Fig. 1A). The relative iNOS content of the
different kidney regions may be better illustrated by the PCR-
Southern technique represented in Figure 2. The agarose gel
separated PCR products were transferred to a nylon membrane
and hybridized with an antisense probe to an iNOS sequence
between the PCR primers. Again, the outer medulla was found
to contain the greatest amount of iNOS mRNA of the kidney.
There are smaller but detectable amounts of iNOS mRNA in the
cortex and inner medulla (Fig. 2). The PCR-Southern technique
further confirms the identity of the amplified product as 1NOS.
The kidney cortex was mechanically separated into glomeruli
and tubule structures by sieving. The cDNA prepared from the
purified glomeruli and tubule was amplified for iNOS by PCR.
This revealed that iNOS mRNA was more abundant in glomer-
uli than tubules (Fig. 3 A and B). The cDNA from glomeruli and
tubules had previously been normalized for the amount of
GAPDH mRNA.
Analysis of iNOS cDNA
The PCR products of iNOS mRNA from glomeruli and the
inner stripe of the outer medulla were separately ligated into the
pCRII vector. The insert was completely sequenced by the
dideoxy chain termination technique using both the forward and
reverse primers. This indicates that indeed the product is iNOS
and not one of the constitutive NOS mRNAs. The full sequence
of the iNOS product between but not including the PCR primers
is seen in Figure 4. Differences between our rat kidney iNOS
sequence and the published murine macrophage iNOS se-
quence [5, 6] are indicated by a lower case letter. Where the
base change led to a different amino acid, the murine macro-
phage amino acid is indicated below the nucleotide sequence.
Three of the six base changes in the calmodulin binding region
result in amino acid changes. None of the five base changes in
the FMN binding region led to changes in amino acid sequence.
This same entire sequence was found in the glomenili and inner
stripe of the outer medulla. The inner stripe was used in order
to avoid inadvertent inclusion of glomeruli in the sample. This
identical sequence was found using amplification products
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Fig. 5. Amplification of iNOS mRNA (A) and GAPDH mRNA (B) by PCR from ,nicrodissected tubule segments and vascular elements of the
outer medulla. The iNOS mRNA was detected by ethidium bromide (A) or the PCR-Southern technique (B) while the relative GAPDH mRNA
content was determined by an ethidium bromide stained agarose gel (C).
derived from cDNA constructed from the kidneys of five
different animals. Furthermore, several independent clones
from individual animals yield the same sequence thereby min-
imizing the possibility of two or more forms of iNOS in the
kidney.
The INOS mRNA content of microdissected outer medulla
The outer medulla was dissected free from slices of rat kidney
that had been pre-perfused with a collagenase-containing solu-
tion. The outer medulla was, in turn, microdissected into
constituent PST, MTAL, MCD tubule segments and the VRB.
The iNOS mRNA was amplified from the cDNA prepared from
each defined segment. As shown in Figure 5, within the outer
medulla the bulk of the iNOS mRNA was within the MTAL
[when the PCR products were visualized by either ethidium
bromide (Fig. 5A), or by the PCR-Southern technique (Fig.
SB)]. The amount of cDNA used for the iNOS amplification was
normalized for the amount of GAPDH mRNA (Fig. 5). There
were small amounts of iNOS mRNA in the MCD and in the
VRB. There was no detectable iNOS mRNA in the PST.
Effect of endotoxin on iNOS mRNA
LPS will induce iNOS mRNA production in mesangial cells
[16, 23] and will induce hNOS mRNA in hepatocytes [11]. We
pretreated animals with LPS for 24 hours prior to the harvesting
of the kidney sections, the liver and resident peritoneal macro-
phages. The iNOS and GAPDH mRNA were amplified from
each tissue or cell source. As shown in Figure 6A and 6B, LPS
treatment caused an over 20-fold increase of iNOS mRNA
expression within the peritoneal macrophages or in the liver.
Within the kidney there were at least 10-fold increases in iNOS
mRNA expression within the glomeruli. In contrast, there was
only a two- to threefold increase in iNOS expression within the
outer medulla (Fig. 6 A and B). The amount of cDNA was
essentially normalized for the amount of GAPDH mRNA (Fig.
6C). Within different regions of the kidney it is seen that LPS
treatment caused an induction of iNOS mRNA (Fig. 7A) when
the cDNA was again normalized for the amount of GAPDH
mRNA (Fig. 7B). This induction ranged from about 20-fold for
the inner medulla to threefold for the outer medulla.
Discussion
This investigation provides evidence for a steady state level
of iNOS mRNA in the kidney of normal rats. This mRNA was
most abundant in the outer medulla when normalized for the
amount of GAPDH mRNA. Upon microdissection of the outer
medulla into constituent PST, MTAL, MCD and VRB it was
found that the major site of iNOS mRNA was the MTAL when
normalized for the GAPDH mRNA content. The conclusion
that this mRNA represents an inducible form of NOS is based
upon the derived nucleotide sequence of the cloned PCR
product. The oligonucleotide primers were constructed based
on the sequence of munne macrophage iNOS [5, 6]. The
expected amplification product of 576 bp was synthesized by
PCR. If either mRNA of the constitutive bNOS or eNOS
enzymes was expressed a 699 bp product would have been
observed [4, 8—10]. A 699 bp product was not observed with
either ethidium bromide staining or by the labeled antisense
probe used for the PCR-Southern blot. The sequence of our
PCR product is similar to that of iNOS and considerably
different from the sequence of hNOS [11].
The existence of iNOS in the normal kidney could be related
to the presence of four cell types. First, resident leukocytes of
the kidney [29, 30]. Second, type II interstitial cells, described
as macrophage-like [31, 32]. Third, endothelial cells [12, 331 of
the vascular elements within the outer medulla. Fourth, intrin-
sic renal tubular cells. While there are resident leukocytes in the
normal kidney they are primarily in the cortex [29, 30]. The
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Fig. 6. The effect of LPS-ireatment on the iNOS mRNA content of macrophages (Mac), liver (Liv), glomeruli (Glom) and outer medulla (OM).
The INOS mRNA content was determined by ethidium bromide (A) or the PCR-Southern technique (B), while the relative GAPDH mRNA content
was determined by an ethidium bromide-stained agarose gel (C).
abundance of the macrophage-like type II interstitial cells is
increased in the outer medulla compared to the cortex but
decreased in the inner medulla [31, 321. Recently, Markewitz,
Michael and Kohan have found expression of iNOS in cultured
kidney proximal tubule and inner medullary cells [24]. Signifi-
cant nitrite/nitrate production or iNOS mRNA was present,
however, only after cytokine stimulation. We found significant
amounts of iNOS mRNA in the MTAL tubules dissected from
the outer medulla. There was detectable but modest amounts of
the iNOS mRNA present in the MCD tubules and the VRB.
This suggests that tubular epithelial cells of the MTAL within
the outer medulla of the normal rat kidney contain a "steady
state" level of what is considered an inducible form of NOS.
Although endothelial cells have the capacity for induction of an
iNOS mRNA [12, 331 there is no significant basal level of this
mRNA in the VRB. It is quite possible that some of the increase
in iNOS mRNA in the outer medulla, due to LPS treatment, is
in the VRB. This would minimize the inductive capacity within
the MTAL. The environment within the outer medulla may
maintain a basal presence of what would otherwise be an
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Fig. 7. The effect of LPS-treatment on the iNOS mRNA content of different regions of the rat kidney. The 1NOS mRNA content of the glomeruli
(Glom), cortex (C), outer medullar (OM) and inner medulla (IM) from rats treated or not with LPS was determined by ethidium bromide (A). The
relative GAPDH mRNA content was determined by an ethidium bromide-stained agarose gel (B).
inductive process. It is possible that resident leukocytes or the
macrophage-like interstitial cells also contain iNOS mRNA;
however, these cells may be lost in the process of microdissec-
tion.
This distribution of iNOS mRNA differs from that for the
bNOS mRNA found by Terada and coworkers, which was also
normalized for the amount of GAPDH mRNA [22]. These
authors found significant amounts of bNOS mRNA in the initial
and terminal parts of the inner medullary collecting duct. Less
mRNA for bNOS was found in cortical and outer medullary
collecting duct, inner medullary thin limb and glomeruli. The
iNOS mRNA of macrophages [5, 6] and a variety of tissues of
the rat [34] including glomerular mesangial cells [16, 23] is
dramatically induced by LPS. We also found that LPS treat-
ment of the intact rat leads to increases in the iNOS mRNA
content within different regions of the kidney as well as in
peritoneal macrophages and the liver. There were at least 10- to
20-fold increases in the iNOS content of the peritoneal macro-
phages, liver, glomeruli and the inner medulla in response to
LPS administration. In contrast, endotoxin treatment caused a
two- to threefold increase in the iNOS mRNA content of the
outer medulla. The iNOS measured in the liver is in all
probability hNOS. Our PCR primers and the antisense PCR-
Southern probe would be capable of amplifying and detecting
this product based upon the similarities in sequence of macro-
phage iNOS and hepatocyte hNOS [11]. The sequence of Figure
4, however, establishes that our PCR-amplified product is more
similar to iNOS of the macrophage [5, 6] than hNOS of the
hepatocyte [11]. Regardless of whether the iNOS mRNA is
present in tubular, vascular or interstitial cells it is evident that
there is a tonic presence in the normal kidney. Whether there is
additional induction of iNOS mRNA in the intact in situ
pathologic kidney awaits further testing.
A major question remaining concerns the physiologic func-
tion of iNOS in the normal kidney and in particular the outer
medulla. The presence of iNOS is usually associated with a
sustained need for large amounts of NO [3]. Such needs usually
relate to cytotoxicity [3]. It is possible, however, in the setting
of the medulla, that a sustained production of NO may be
necessary for blood flow. Studies by Brezis et al have indicated
that NOS regulates medullary blood flow of the kidney [35]. The
thick ascending limb is the site of Tamm-Horsfall protein
synthesis [36], which is believed to bind and inactivate various
cytokines [37]. While the Tamm-Horsfall protein may serve as
a buffer for cytokines the low level of dissociation may be
sufficient to induce iNOS mRNA. It is possible that synergy
among the cytokines attracted by and concentrated by the
glycoprotein is responsible for this "steady state" induction.
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